Download PDF
Horm Metab Res 2016; 48(03): 185-190
DOI: 10.1055/s-0035-1559604
Endocrine Care

Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome

M. Razavi
1   Department of Gynecology and Obstetrics, School of Medicine, Ardabil University of Medical Sciences, Ardabil, I. R. Iran
,
M. Jamilian
2   Department of Gynecology and Obstetrics, School of Medicine, Arak University of Medical Sciences, Arak, I. R. Iran
,
Z. Fakhrieh Kashan
3   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I. R. Iran
,
Z. Heidar
4   Department of Gynecology and Obstetrics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, I. R. Iran
,
M. Mohseni
3   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I. R. Iran
,
Y. Ghandi
3   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I. R. Iran
,
T. Bagherian
3   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I. R. Iran
,
Z. Asemi
3   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I. R. Iran
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Selenium supplementation could be effective on reproductive outcomes, biomarkers of inflammation, and oxidative stress among women with polycystic ovary syndrome (PCOS). The aim of the study was to determine the effects of selenium supplementation on reproductive outcomes, biomarkers of inflammation, and oxidative stress in PCOS patients. The present randomized double-blind, placebo-controlled trial was conducted on 64 women aged 18–40 years old with PCOS at the clinic affiliated to Ardabil University of Medical Sciences, Ardabil, Iran. The participants were randomly assigned to 2 groups receiving either 200 μg selenium daily (n=32) or placebo (n=32) for 8 weeks. Hormonal profiles, biomarkers of inflammation, and oxidative stress were measured and compared both before and after the treatment. After 8 weeks of intervention, pregnancy rate in the selenium group was higher than in the placebo group: 18.8 (6/32) vs. 3.1% (1/32), p=0.04. In addition, alopecia (40.6 vs. 9.4%, p=0.004) and acne (46.9 vs. 12.5 %, p=0.003) decreased following the consumption of selenium supplements compared with placebo. Additionally, patients who received selenium supplements had significantly decreased serum dehydroepiandrosterone (DHEA) levels (p=0.02), hirsutism (modified Ferriman–Gallwey scores) (p<0.001), serum high sensitivity C-reactive protein (hs-CRP) (p=0.02), and plasma malondialdehyde (MDA) levels (p=0.01) compared with placebo. We did not observe any significant effects of taking selenium supplements on other hormonal profiles, nitric oxide (NO), and other biomarkers of oxidative stress. Taken together, selenium supplementation for 8 weeks among PCOS women had beneficial effects on reproductive outcomes, DHEA, hs-CRP, and MDA levels.

Key words

selenium - supplementation - polycystic ovary syndrome - reproductive outcomes - inflammation - oxidative stress

Supporting Information

    Supporting Information for this article is availableonline at http://www.thieme-connect.de/products.
  • Supporting Information


Publication History

Received: 16 April 2015

Accepted: 02 July 2015

Article published online:
12 August 2015

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Refers to:

Note of Concern: Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary SyndromeHorm Metab Res 2016; 48(03): e4-e4
DOI: 10.1055/a-1736-8692

 

  • References

  • 1 Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Horm Metab Res 2015; 47: 232-238
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Homburg R. Polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2008; 22: 261-274
    CrossrefPubMedGoogle Scholar
  • 3 Amooee S, Parsanezhad ME, Ravanbod Shirazi M, Alborzi S, Samsami A. Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial. Iran J Reprod Med 2013; 11: 611-618
    PubMedGoogle Scholar
  • 4 Macut D, Bjekic-Macut J, Savic-Radojevic A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res 2013; 40: 51-63
    CrossrefPubMedGoogle Scholar
  • 5 Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 336-340
    CrossrefPubMedGoogle Scholar
  • 6 Li S, Tao T, Wang L, Mao X, Zheng J, Zhao A, Liu W. The expression of 11beta-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects. Horm Metab Res 2013; 45: 802-807
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Cicchitano P, Dentamaro I, Carbonara R, Bulzis G, Dachille A, Caputo P, Riccardi R, Locorotondo M, Mandurino C, Matteo Ciccone M. Cardiovascular Risk in Women With PCOS. Int J Endocrinol Metab 2012; 10: 611-618
    CrossrefPubMedGoogle Scholar
  • 8 Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S. Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertil Steril 2011; 95: 310-313
    CrossrefPubMedGoogle Scholar
  • 9 Anagnostis P, Efstathiadou ZA, Gougoura S, Polyzos SA, Karathanasi E, Dritsa P, Kita M, Koukoulis GN. Oxidative stress and reduced antioxidative status, along with endothelial dysfunction in acromegaly. Horm Metab Res 2013; 45: 314-318
    PubMedGoogle Scholar
  • 10 Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2012; 5: CD003053 DOI: 10.1002/14651858.
    CrossrefPubMedGoogle Scholar
  • 11 Mistry HD, Broughton Pipkin F, Redman CW, Poston L. Selenium in reproductive health. Am J Obstet Gynecol 2012; 206: 21-30
    CrossrefPubMedGoogle Scholar
  • 12 Kose SA, Naziroglu M. Selenium reduces oxidative stress and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome. Biol Trace Elem Res 2014; 158: 136-142
    CrossrefPubMedGoogle Scholar
  • 13 Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 2015; 82: 885-891
    CrossrefPubMedGoogle Scholar
  • 14 Valenta J, Brodska H, Drabek T, Hendl J, Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 2011; 37: 808-815
    CrossrefPubMedGoogle Scholar
  • 15 Yurekli VA, Naziroglu M. Selenium and topiramate attenuates blood oxidative toxicity in patients with epilepsy: a clinical pilot study. Biol Trace Elem Res 2013; 152: 180-186
    CrossrefPubMedGoogle Scholar
  • 16 Kang BP, Bansal MP, Mehta U. Selenium supplementation and diet induced hypercholesterolemia in the rat: changes in lipid levels, malonyldialdehyde production and the nitric oxide synthase activity. Gen Physiol Biophys 1998; 17: 71-78
    PubMedGoogle Scholar
  • 17 Zeng J, Zhou J, Huang K. Effect of selenium on pancreatic proinflammatory cytokines in streptozotocin-induced diabetic mice. J Nutr Biochem 2009; 20: 530-536
    CrossrefPubMedGoogle Scholar
  • 18 Ruder EH, Hartman TJ, Goldman MB. Impact of oxidative stress on female fertility. Curr Opin Obstet Gynecol 2009; 21: 219-222
    CrossrefPubMedGoogle Scholar
  • 19 Rafraf M, Mahdavi R, Rashidi MR. Serum selenium levels in healthy women in Tabriz, Iran. Food Nutr Bull 2008; 29: 83-86
    CrossrefPubMedGoogle Scholar
  • 20 Mansour A, Ahadi Z, Qorbani M, Hosseini S. Association between dietary intake and seasonal variations in postmenopausal women. J Diabetes Metab Disord 2014; 13: 52
    CrossrefPubMedGoogle Scholar
  • 21 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
    CrossrefPubMedGoogle Scholar
  • 22 Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815-830
    CrossrefPubMedGoogle Scholar
  • 23 Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 2000; 73: 1149-1154
    CrossrefPubMedGoogle Scholar
  • 24 Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King Jr. LE, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D. Alopecia areata investigational assessment guidelines – Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-447
    CrossrefPubMedGoogle Scholar
  • 25 Tatsch E, Bochi GV, Pereira Rda S, Kober H, Agertt VA, de Campos MM, Gomes P, Duarte MM, Moresco RN. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 2011; 44: 348-350
    CrossrefPubMedGoogle Scholar
  • 26 Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 1996; 239: 70-76
    CrossrefPubMedGoogle Scholar
  • 27 Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985; 105: 581-584
    PubMedGoogle Scholar
  • 28 Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515-540
    CrossrefPubMedGoogle Scholar
  • 29 Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A. Effects of selenium supplementation on glucose homeostasis, inflammation and oxidative stress in gestational diabetes: randomized, double-blind, placebo-controlled trial. Nutrition 2015; DOI: 10.1016/j.nut.2015.04.014.
    CrossrefPubMedGoogle Scholar
  • 30 Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 804-810
    CrossrefPubMedGoogle Scholar
  • 31 Johnson LJ, Meacham SL, Kruskall LJ. The antioxidants – vitamin C,vitamin E, selenium, and carotenoids. J Agromedicine 2003; 9: 65-82
    CrossrefPubMedGoogle Scholar
  • 32 Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Clark LC, Marshall JR. A report of high-dose selenium supplementation: response and toxicities. J Trace Elem Med Biol 2004; 18: 69-74
    CrossrefPubMedGoogle Scholar
  • 33 Bargiota A, Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab 2012; 3: 27-47
    CrossrefPubMedGoogle Scholar
  • 34 Munoz C, Carson AF, McCoy MA, Dawson LE, Irwin D, Gordon AW, Kilpatrick DJ. Effect of supplementation with barium selenate on the fertility, prolificacy and lambing performance of hill sheep. Vet Rec 2009; 164: 265-271
    CrossrefPubMedGoogle Scholar
  • 35 Arechiga CF, Vazquez-Flores S, Ortiz O, Hernandez-Ceron J, Porras A, McDowell LR, Hansen PJ. Effect of injection of beta-carotene or vitamin E and selenium on fertility of lactating dairy cows. Theriogenology 1998; 50: 65-76
    CrossrefPubMedGoogle Scholar
  • 36 Paszkowski T, Traub AI, Robinson SY, McMaster D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta 1995; 236: 173-180
    CrossrefPubMedGoogle Scholar
  • 37 Ozkaya MO, Naziroglu M, Barak C, Berkkanoglu M. Effects of multivitamin/mineral supplementation on trace element levels in serum and follicular fluid of women undergoing in vitro fertilization (IVF). Biol Trace Elem Res 2011; 139: 1-9
    CrossrefPubMedGoogle Scholar
  • 38 Edassery SL, Shatavi SV, Kunkel JP, Hauer C, Brucker C, Penumatsa K, Yu Y, Dias JA, Luborsky JL. Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril 2010; 94: 2636-2641
    CrossrefPubMedGoogle Scholar
  • 39 Jukola E, Hakkarainen J, Saloniemi H, Sankari S. Blood selenium, vitamin E, vitamin A, and beta-carotene concentrations and udder health, fertility treatments, and fertility. J Dairy Sci 1996; 79: 838-845
    CrossrefPubMedGoogle Scholar
  • 40 Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update 2008; 14: 345-357
    CrossrefPubMedGoogle Scholar
  • 41 Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update 2007; 13: 163-174
    CrossrefPubMedGoogle Scholar
  • 42 Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol 2001; 41: 65-68
    CrossrefPubMedGoogle Scholar
  • 43 Vlaisavljevic V, Kovac V, Sajko MC. Impact of insulin resistance on the developmental potential of immature oocytes retrieved from human chorionic gonadotropin-primed women with polycystic ovary syndrome undergoing in vitro maturation. Fertil Steril 2009; 91: 957-959
    CrossrefPubMedGoogle Scholar
  • 44 Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbicer HC. Plasma selenium levels in Turkish women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013; 168: 183-186
    CrossrefPubMedGoogle Scholar
  • 45 Hauner H, Ditschuneit HH, Pal SB, Moncayo R, Pfeiffer EF. Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism 1988; 37: 281-286
    CrossrefPubMedGoogle Scholar
  • 46 Munzker J, Hofer D, Trummer C, Ulbing M, Harger A, Pieber T, Owen L, Keevil B, Brabant G, Lerchbaum E, Obermayer-Pietsch B. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. J Clin Endocrinol Metab 2015; 100: 653-660
    CrossrefPubMedGoogle Scholar
  • 47 Suresh S, Vijayakumar T. Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism. Indian J Clin Biochem 2015; 30: 345-350
    CrossrefPubMedGoogle Scholar
  • 48 Jalili M, Kolahi S, Aref-Hosseini SR, Mamegani ME, Hekmatdoost A. Beneficial role of antioxidants on clinical outcomes and erythrocyte antioxidant parameters in rheumatoid arthritis patients. Int J Prev Med 2014; 5: 835-840
    PubMedGoogle Scholar
  • 49 Madaric A, Kadrabova J, Krajcovicova-Kudlackova M, Valachovicova M, Spustova V, Mislanova C, Kajaba I, Blazicek P. The effect of bioactive complex of quercetin, selenium, catechins and curcumin on cardiovascular risk markers in healthy population after a two month consumption. Bratisl Lek Listy 2013; 114: 84-87
    PubMedGoogle Scholar
  • 50 Alizadeh M, Safaeiyan A, Ostadrahimi A, Estakhri R, Daneghian S, Ghaffari A, Gargari BP. Effect of l-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab 2012; 60: 157-168
    CrossrefPubMedGoogle Scholar
  • 51 Pawelczak M, Rosenthal J, Milla S, Liu YH, Shah B. Evaluation of the Pro-inflammatory Cytokine Tumor Necrosis Factor-alpha in Adolescents with Polycystic Ovary Syndrome. J Pediatr Adolesc Gynecol 2014; 27: 356-359
    CrossrefPubMedGoogle Scholar
  • 52 He YT, Liu DW, Ding LY, Li Q, Xiao YH. Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis. World J Gastroenterol 2004; 10: 703-706
    CrossrefPubMedGoogle Scholar
  • 53 Duntas LH. Selenium and inflammation: underlying anti-inflammatory mechanisms. Horm Metab Res 2009; 41: 443-447
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Salehi M, Sohrabi Z, Ekramzadeh M, Fallahzadeh MK, Ayatollahi M, Geramizadeh B, Hassanzadeh J, Sagheb MM. Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Nephrol Dial Transplant 2013; 28: 716-723
    CrossrefPubMedGoogle Scholar
  • 55 Guney M. Selenium-vitamin E combination modulates endometrial lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat. Biol Trace Elem Res 2012; 149: 234-240
    CrossrefPubMedGoogle Scholar
  • 56 Savory LA, Kerr CJ, Whiting P, Finer N, McEneny J, Ashton T. Selenium supplementation and exercise: effect on oxidant stress in overweight adults. Obesity (Silver Spring) 2012; 20: 794-801
    CrossrefPubMedGoogle Scholar
  • 57 Gupta S, Ghulmiyyah J, Sharma R, Halabi J, Agarwal A. Power of proteomics in linking oxidative stress and female infertility. Biomed Res Int 2014; 916212
    PubMedGoogle Scholar
  • 58 Ozturk IC, Batcioglu K, Karatas F, Hazneci E, Genc M. Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. Indian J Dermatol 2008; 53: 106-110
    CrossrefPubMedGoogle Scholar
  • 59 Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Bjorkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology 2012; 55: 1112-1121
    CrossrefPubMedGoogle Scholar